These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
373 related items for PubMed ID: 34937501
1. Long-term outcomes of combined transarterial chemoembolization and radiofrequency ablation versus RFA monotherapy for single hepatocellular carcinoma ≤3 cm: emphasis on local tumor progression. Cao S, Zou Y, Lyu T, Fan Z, Guan H, Song L, Tong X, Wang J. Int J Hyperthermia; 2022; 39(1):1-7. PubMed ID: 34937501 [Abstract] [Full Text] [Related]
2. Combined transarterial chemoembolization and radiofrequency ablation for subphrenic versus nonsubphrenic hepatocellular carcinoma: a propensity score matched study. Kim JG, Cho SK, Hyun D, Shin SW, Park KB, Park HS, Choo SW, Do YS, Woo SY, Baek SY. Abdom Radiol (NY); 2021 Dec; 46(12):5735-5745. PubMed ID: 34581928 [Abstract] [Full Text] [Related]
3. Drug-Eluting Bead Transarterial Chemoembolization Versus Radiofrequency Ablation as an Initial Treatment of Single Small (≤ 3 cm) Hepatocellular Carcinoma. Lee S, Jeong YY, Lee BC, Shin SS, Heo SH, Kim HO, Park C, Jeong WG. J Korean Med Sci; 2023 Oct 30; 38(42):e362. PubMed ID: 37904659 [Abstract] [Full Text] [Related]
4. Combined transarterial chemoembolization and radiofrequency ablation for small treatment-naïve hepatocellular carcinoma infeasible for ultrasound-guided radiofrequency ablation: long-term outcomes. Hyun D, Cho SK, Shin SW, Park KB, Lee SY, Park HS, Do YS. Acta Radiol; 2018 Jul 30; 59(7):773-781. PubMed ID: 29034691 [Abstract] [Full Text] [Related]
5. Early Stage Hepatocellular Carcinomas Not Feasible for Ultrasound-Guided Radiofrequency Ablation: Comparison of Transarterial Chemoembolization Alone and Combined Therapy with Transarterial Chemoembolization and Radiofrequency Ablation. Hyun D, Cho SK, Shin SW, Park KB, Park HS, Choo SW, Do YS, Choo IW, Lee MW, Rhim H, Lim HK. Cardiovasc Intervent Radiol; 2016 Mar 30; 39(3):417-25. PubMed ID: 26246215 [Abstract] [Full Text] [Related]
6. Combined radiofrequency ablation or microwave ablation with transarterial chemoembolization can increase efficiency in intermediate-stage hepatocellular carcinoma without more complication: a systematic review and meta-analysis. Yang Y, Yu H, Qi L, Liu C, Feng Y, Qi J, Li J, Zhu Q. Int J Hyperthermia; 2022 Mar 30; 39(1):455-465. PubMed ID: 35271786 [Abstract] [Full Text] [Related]
7. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone. Kim JW, Kim JH, Won HJ, Shin YM, Yoon HK, Sung KB, Kim PN. Eur J Radiol; 2012 Mar 30; 81(3):e189-93. PubMed ID: 21353417 [Abstract] [Full Text] [Related]
8. Long-term outcome of percutaneous radiofrequency ablation for periportal hepatocellular carcinoma: tumor recurrence or progression, survival and clinical significance. Cao S, Lyu T, Fan Z, Guan H, Song L, Tong X, Wang J, Zou Y. Cancer Imaging; 2022 Jan 04; 22(1):2. PubMed ID: 34983650 [Abstract] [Full Text] [Related]
9. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study. Ren Y, Cao Y, Ma H, Kan X, Zhou C, Liu J, Shi Q, Feng G, Xiong B, Zheng C. BMC Cancer; 2019 Oct 22; 19(1):983. PubMed ID: 31640620 [Abstract] [Full Text] [Related]
10. Combination therapy of transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) for small hepatocellular carcinoma: comparison with TACE or RFA monotherapy. Kim W, Cho SK, Shin SW, Hyun D, Lee MW, Rhim H. Abdom Radiol (NY); 2019 Jun 22; 44(6):2283-2292. PubMed ID: 30806742 [Abstract] [Full Text] [Related]
11. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma. Song MJ, Bae SH, Lee JS, Lee SW, Song DS, You CR, Choi JY, Yoon SK. Korean J Intern Med; 2016 Mar 22; 31(2):242-52. PubMed ID: 26874512 [Abstract] [Full Text] [Related]
12. Transarterial chemoembolization plus multi-imaging-guided radiofrequency ablation for elimination of hepatocellular carcinoma nodules measuring 3.1 to 5.0 cm: a single-center study. Haochen W, Jian W, Li S, Tianshi L, Xiaoqiang T, Yinghua Z. J Int Med Res; 2018 Jul 22; 46(7):2650-2657. PubMed ID: 29683022 [Abstract] [Full Text] [Related]
13. Sequential transarterial chemoembolization and early radiofrequency ablation improves clinical outcomes for early-intermediate hepatocellular carcinoma in a 10-year single-center comparative study. Yan L, Ren Y, Qian K, Kan X, Zhang H, Chen L, Liang B, Zheng C. BMC Gastroenterol; 2021 Apr 20; 21(1):182. PubMed ID: 33879085 [Abstract] [Full Text] [Related]
14. Combined transcatheter arterial chemoembolization and radiofrequency ablation in single-session for solitary hepatocellular carcinoma larger than 7 cm. Yan JY, Zhang JL, Wang MQ, Yuan K, Bai YH, Wang Y, Xin HN, Wang ZJ, Liu FY, Duan F, Fu JX. Asia Pac J Clin Oncol; 2018 Aug 20; 14(4):300-309. PubMed ID: 29124894 [Abstract] [Full Text] [Related]
15. Efficacy of transarterial chemoembolization compared with radiofrequency ablation for the treatment of recurrent hepatocellular carcinoma after radiofrequency ablation. Wang X, Liang H, Lu Z. Minim Invasive Ther Allied Technol; 2020 Dec 20; 29(6):344-352. PubMed ID: 31375044 [Abstract] [Full Text] [Related]
16. Chemoembolization versus radiofrequency ablation for single small (≤ 3 cm) hepatocellular carcinoma: a propensity score matching analysis. Kim GH, Kim JH, Shim JH, Kim SY, Kim PH, Ko HK, Gwon DI, Shin JH, Lee SJ, Chu HH, Won HJ, Shin YM, Kim N. Eur Radiol; 2024 Sep 20; 34(9):5517-5528. PubMed ID: 38329504 [Abstract] [Full Text] [Related]
17. Rescue therapy for local tumor progression after radiofrequency ablation of small hepatocellular carcinoma: a comparison between repeated ablation and transcatheter arterial chemoembolization. Cha DI, Lee MW, Ahn SH, Song KD, Kang TW, Sinn DH, Rhim H. Br J Radiol; 2023 Jun 01; 96(1146):20211037. PubMed ID: 37017490 [Abstract] [Full Text] [Related]
18. Transarterial Chemoembolization Monotherapy in Combination with Radiofrequency Ablation or Percutaneous Ethanol Injection for Hepatocellular Carcinoma. Xu C, Lv PH, Huang XE, Wang SX, Sun L, Wang FA. Asian Pac J Cancer Prev; 2016 Jun 01; 17(9):4349-4352. PubMed ID: 27797242 [Abstract] [Full Text] [Related]
19. Treatment of Small Hepatocellular Carcinoma (≤2 cm) in the Caudate Lobe with Sequential Transcatheter Arterial Chemoembolization and Radiofrequency Ablation. Hyun D, Cho SK, Shin SW, Rhim H, Koh KC, Paik SW. Cardiovasc Intervent Radiol; 2016 Jul 01; 39(7):1015-22. PubMed ID: 26975761 [Abstract] [Full Text] [Related]
20. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma. Ni JY, Liu SS, Xu LF, Sun HL, Chen YT. World J Gastroenterol; 2013 Jun 28; 19(24):3872-82. PubMed ID: 23840128 [Abstract] [Full Text] [Related] Page: [Next] [New Search]